NCT03375957View on ClinicalTrials.gov

Sensitization Study of ATx201 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

February 17, 2018

Study Completion Date

March 15, 2018

Conditions
Sensitivity, Contact
Interventions
DRUG

ATx201

two hundred microliters (200 μL) of test article applied to the test site areas of the upper outer arms

DRUG

ATx201 Placebo Gel

two hundred microliters (200 μL) of placebo applied to the test site areas of the upper outer arms

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, LLC, Springfield

Sponsors

Lead Sponsor

UNION therapeutics
All Listed Sponsors
lead

UNION therapeutics

INDUSTRY

NCT03375957 - Sensitization Study of ATx201 in Healthy Volunteers | Biotech Hunter | Biotech Hunter